Get the tools used by (smart)2 investors.
SP500 0.7%DOW 0.7%FTSE 100 -0.3%NIKKEI 0.4%OIL 0.8%GOLD 0.2%
Sign In
WatchlistsIdeasScreenerData ExplorerChartsSaved Work

Degree of Combined Leverage (DCL) for Alembic Pharmaceuticals Ltd-BO

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

533573: Alembic Pharmaceuticals Ltd-BO

Alembic Pharmaceuticals Limited develops, manufactures, and markets pharmaceutical products in India and internationally. The company provides branded specialty medicines in various therapeutic areas,...

885.20 INR
Price
– INR
Fair Value
–
Upside
725.60 - 1,296.15
52-week range
Create ChartCreate ModelAdd To Watchlist

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Alembic Pharmaceuticals Ltd-BO's Degree of Combined Leverage (DCL):

Mar 2016Mar 2018Mar 2020Mar 2022Mar 20240.0020.0040.0060.0080.00
Performance Summary
  • Alembic Pharmaceuticals Ltd-BO's latest twelve months degree of combined leverage (dcl) is 3.80
  • Alembic Pharmaceuticals Ltd-BO's degree of combined leverage (dcl) for fiscal years ending March 2020 to 2024 averaged 7.98.
  • Alembic Pharmaceuticals Ltd-BO's operated at median degree of combined leverage (dcl) of 3.00 from fiscal years ending March 2020 to 2024.
  • Looking back at the last 5 years, Alembic Pharmaceuticals Ltd-BO's degree of combined leverage (dcl) peaked in March 2022 at 34.83.
  • Alembic Pharmaceuticals Ltd-BO's degree of combined leverage (dcl) hit its 5-year low in March 2023 of -4.40.
  • Alembic Pharmaceuticals Ltd-BO's degree of combined leverage (dcl) decreased in 2021 (0.99, -67.1%) and 2023 (-4.40, -112.6%) and increased in 2020 (3.00, +65.8%), 2022 (34.83, +3,424.5%), and 2024 (5.46, -224.1%).

How does Alembic Pharmaceuticals Ltd-BO's Degree of Combined Leverage (DCL) benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Alembic Pharmaceuticals Ltd-BO because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Alembic Pharmaceuticals Ltd-BO Degree of Combined Leverage (DCL) Benchmarks
NameTickerDegree of Combined Leverage (DCL)
Wockhardt LtdNSEI:WOCKPHARMA-60.70
Gland Pharma LtdNSEI:GLAND0.33
HealthcareSECTOR:HLTH.IN1.61
Abbott India LtdNSEI:ABBOTINDIA1.61
Zydus Lifesciences LtdNSEI:ZYDUSLIFE1.72
Cipla Ltd.NSEI:CIPLA2.24
GlaxoSmithkline Pharmaceuticals LtdNSEI:GLAXO2.97
Alembic Pharmaceuticals Ltd-BOBSE:5335733.80
Lupin LtdNSEI:LUPIN5.82
Morepen Laboratories LtdNSEI:MOREPENLAB7.53
Pfizer Ltd.NSEI:PFIZER22.73
Glenmark Pharmaceuticals LtdNSEI:GLENMARK24.40

Metric Usage: Degree of Combined Leverage (DCL)

Hide this widget
degree_of_combined_leverage
Slug
number
Datatype
text
Format
current
Default Period
FY, Q, LTM, YTD
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Degree of Combined Leverage (DCL) in the risk category include:

  • Beta (1 Year) - A ratio that measures the risk or volatility of a company's share price in comparison to the market as a whole. Beta (1 Year) is calculated using one year of weekly returns.
  • Quick Ratio - A ratio used to assess a company's short-term liquidity.
  • Debt / Total Equity - A ratio that measures the level of the debt relative to the book value of total equity.
  • Cash Ratio - A strict ratio used to assess a company's short-term liquidity.
View Full List

Search for metric or datapoint

Degree of Combined Leverage (DCL)

Definition of Degree of Combined Leverage (DCL)

Hide this widget
The degree of combined leverage expands on the degree of operating leverage to provide a view of a company's ability to generate profits from sales. It multiplies DOL and DFL.

Sector Benchmark Analysis

All rights reserved. Terms Of Use